JP2014193889A5 - - Google Patents

Download PDF

Info

Publication number
JP2014193889A5
JP2014193889A5 JP2014099667A JP2014099667A JP2014193889A5 JP 2014193889 A5 JP2014193889 A5 JP 2014193889A5 JP 2014099667 A JP2014099667 A JP 2014099667A JP 2014099667 A JP2014099667 A JP 2014099667A JP 2014193889 A5 JP2014193889 A5 JP 2014193889A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
substituted
hal
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014099667A
Other languages
English (en)
Japanese (ja)
Other versions
JP5876527B2 (ja
JP2014193889A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014193889A publication Critical patent/JP2014193889A/ja
Publication of JP2014193889A5 publication Critical patent/JP2014193889A5/ja
Application granted granted Critical
Publication of JP5876527B2 publication Critical patent/JP5876527B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014099667A 2007-04-11 2014-05-13 診断用画像及び放射線治療用の葉酸複合体及び対応する金属キレート錯体 Expired - Fee Related JP5876527B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105980.2 2007-04-11
EP07105980 2007-04-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010502521A Division JP5710246B2 (ja) 2007-04-11 2008-04-11 診断用画像及び放射線治療用の葉酸複合体及び対応する金属キレート錯体

Publications (3)

Publication Number Publication Date
JP2014193889A JP2014193889A (ja) 2014-10-09
JP2014193889A5 true JP2014193889A5 (cg-RX-API-DMAC10.html) 2015-03-19
JP5876527B2 JP5876527B2 (ja) 2016-03-02

Family

ID=39683755

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010502521A Expired - Fee Related JP5710246B2 (ja) 2007-04-11 2008-04-11 診断用画像及び放射線治療用の葉酸複合体及び対応する金属キレート錯体
JP2014099667A Expired - Fee Related JP5876527B2 (ja) 2007-04-11 2014-05-13 診断用画像及び放射線治療用の葉酸複合体及び対応する金属キレート錯体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010502521A Expired - Fee Related JP5710246B2 (ja) 2007-04-11 2008-04-11 診断用画像及び放射線治療用の葉酸複合体及び対応する金属キレート錯体

Country Status (11)

Country Link
US (2) US20100143249A1 (cg-RX-API-DMAC10.html)
EP (1) EP2146995A1 (cg-RX-API-DMAC10.html)
JP (2) JP5710246B2 (cg-RX-API-DMAC10.html)
KR (2) KR101605426B1 (cg-RX-API-DMAC10.html)
CN (1) CN101646672B (cg-RX-API-DMAC10.html)
AU (1) AU2008237935B2 (cg-RX-API-DMAC10.html)
CA (1) CA2670385C (cg-RX-API-DMAC10.html)
EA (1) EA200901344A1 (cg-RX-API-DMAC10.html)
IL (1) IL201250A0 (cg-RX-API-DMAC10.html)
WO (1) WO2008125618A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200903483B (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101605426B1 (ko) * 2007-04-11 2016-03-22 메르크 앤드 씨에 진단 이미징 및 방사선치료에 사용하기 위한 폴레이트-컨쥬게이트 및 대응하는 금속-킬레이트 착물
US8236284B1 (en) * 2008-04-02 2012-08-07 University Of Central Florida Research Foundation, Inc. Multimodal, multifunctional polymer coated nanoparticles
FR2942227B1 (fr) * 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
WO2011084571A2 (en) 2009-12-16 2011-07-14 Mallinckrodt Inc. Azide derivatives for phototherapy
AU2012296937B2 (en) * 2011-08-17 2017-10-12 Merck & Cie Folate conjugates of albumin-binding entities
EA201401225A1 (ru) 2012-05-08 2015-04-30 Мерк Э Сие F-меченые аналоги фолата/антифолата
JP2018504422A (ja) * 2015-02-06 2018-02-15 センプラ ファーマシューティカルズ,インコーポレイテッド 4−アジドブチルアミンおよびその調製方法
WO2020256210A1 (ko) 2019-06-20 2020-12-24 주식회사 쿼드마이너 네트워크 포렌식 시스템 및 이를 이용한 네트워크 포렌식 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093382A (en) * 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
DE60231868D1 (de) 2001-04-24 2009-05-20 Purdue Research Foundation Folat-mimetika und deren folatrezeptorbindende konjugate
DK2258401T3 (da) * 2002-05-06 2014-10-13 Endocyte Inc Folat-receptor targetede billeddannelsesmidler
ATE453865T1 (de) * 2003-04-29 2010-01-15 Univ Zuerich An einem biomolekül gebundenen n epsilon- und/oder n alpha derivatisiertem und organisch- geschütztem l-histidin zur hoch-effizienter markierung mit (m(h2o)3(co)3)+ mittels fac koordinierung
US9265746B2 (en) * 2006-05-31 2016-02-23 Merck & Cie Method for cell-specific targeting
KR101605426B1 (ko) * 2007-04-11 2016-03-22 메르크 앤드 씨에 진단 이미징 및 방사선치료에 사용하기 위한 폴레이트-컨쥬게이트 및 대응하는 금속-킬레이트 착물

Similar Documents

Publication Publication Date Title
JP2014193889A5 (cg-RX-API-DMAC10.html)
US11951109B2 (en) EZH2 inhibitors for treating lymphoma
US10201617B2 (en) 3-substituted piperidine-2, 6-diones and non-covalent complexes with albumin
AU2018353150B2 (en) Methods of using EHMT2 inhibitors in treating or preventing blood disorders
ES3017422T3 (en) Spiro compound serving as erk inhibitor, and application thereof
ES2868748T3 (es) Compuesto de piridina
KR102747818B1 (ko) 암 치료용 병용 요법
JP2021130700A (ja) 癌を処置するための併用療法
JP2023071905A (ja) 癌を処置するためのezh2阻害剤
JP6524094B2 (ja) 置換ピリミジンBmi−1阻害剤
CN111770914B (zh) 作为神经激肽-1受体拮抗剂的化合物及其用途
JP7208898B2 (ja) 癌を処置するための併用療法
JP2024001203A (ja) 癌を処置するための併用療法
US11976064B2 (en) Toll-like receptor agonists
JP6538656B2 (ja) 5’−ヌクレオチダーゼ阻害剤およびその治療的使用
EA039630B1 (ru) N-замещенные индольные производные
CA3107548A1 (en) Smad3 inhibitors
WO2020062883A1 (zh) 基于知母菝契皂苷元结构的衍生物、药物组合物及其应用
BR112021005171A2 (pt) derivados de quinuclidina-3-ona e seu uso em tratamento de câncer
Ge et al. Synthesis and biological evaluation of 6-fluoro-3-phenyl-7-piperazinyl quinolone derivatives as potential topoisomerase I inhibitors
KR20080004495A (ko) 암을 치료하기 위한 조합물, 방법 및 조성물
AU2025213600A1 (en) Nurr1 receptor modulators
CN108699030B (zh) 一类取代的氨基六元氮杂环类化合物及其制备和用途
CA2884832C (en) Means and method for treating solid tumours
CA2602199A1 (en) Heteroaryl urea derivatives useful for inhibiting chk1